- Home
- TCRX vs RYM Comparison
TCRX vs RYM Comparison
Compare TCRX & RYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TCRX | RYM |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 45.0M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TCRX | RYM |
|---|---|---|
| Price | $0.75 | $21.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 470.4K | 10.3K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.28 | ★ 59.24 |
| EPS | N/A | ★ 1.49 |
| Revenue | $10,325,000.00 | ★ $17,283,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | $14.91 |
| Revenue Growth | ★ 266.65 | 78.54 |
| 52 Week Low | $0.72 | $14.00 |
| 52 Week High | $2.57 | $53.65 |
Technical Indicators
Market Signals| Indicator | TCRX | RYM |
|---|---|---|
| Relative Strength Index (RSI) | 40.29 | 45.88 |
| Support Level | $0.72 | $15.26 |
| Resistance Level | $0.80 | $29.41 |
| Average True Range (ATR) | 0.04 | 1.79 |
| MACD | 0.01 | 0.20 |
| Stochastic Oscillator | 50.00 | 34.90 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About RYM RYTHM Inc.
Rythm Inc is a USA Based company. The company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.